Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Edwards Lifesciences Corporation logo

Edwards Lifesciences Corporation

Sector: Healthcare   

Industry: Medical Devices

86.90
 
USD
  
0.80
  
(0.93%)
Optionable: Yes  Market Cap: 52,317 M  90-day average vol: 4,372,374

Previous close: 86.1  Open: 85.8  Bid: 84.4  Ask: 87.0
52 week range    
60.57   
   94.87
Peers   
BSX / 
MMSI / 
LMAT / 
ICUI / 
MDT / 
Last updated: Wednesday 21st February 2024
49
MarketXLS Rank
25
Value
61
Technical
63
Quality

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

BSX

62 B55.742.91

CRY

1 B638.317.88

ICUI

5 B42.4213.4

LMAT

0.01051 B31.841.94

MDT

0.0245139 B29.8101.99

MMSI

3 B7255.35
Financials

EW Income Statement

Annual
Dec-13Dec-14Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
Amortization of intangibles385 M376 M628 M626 M1,127 M1,112 M1,168 M1,173 M1,168 M
Basic EPS from continuing operations3.483.812.32.672.773.451.681.322.41
Basic EPS total3.483.812.32.672.773.451.681.322.412.46
Basic weighted shares outstanding112 M213 M216 M213 M211 M209 M625 M623 M623 M619 M
Cost of sales517 M626 M617 M797 M875 M939 M1,114 M1,081 M1,249 M1,080 M
Depreciation63 M58 M59 M64 M74 M75 M85 M102 M127 M-134 M
DepreciationAndAmortization63 M58 M59 M64 M74 M75 M85 M102 M127 M-134 M
Diluted EPS total3.423.742.252.612.73.381.641.32.382.44
Diluted normalized net income/share3.423.742.252.612.73.381.641.32.38
Diluted weighted shares outstanding114 M217 M220 M218 M216 M214 M637 M632 M631 M624 M
GeneralAndAdministrativeExpense733 M858 M851 M905 M991 M1,089 M1,242 M1,228 M1,494 M
Gross operating profit1,529 M1,697 M1,877 M2,166 M2,560 M2,783 M3,234 M3,306 M3,984 M4,302 M
Income before tax511 M1,144 M622 M738 M1,035 M761 M1,167 M917 M1,702 M1,767 M
Income restructuring and M&A10 M
Income taxes122 M333 M128 M168 M451 M39 M120 M93 M199 M246 M
Interest income5 M6 M8 M11 M20 M32 M32 M23 M17 M36 M
InterestExpenseNonOperating10 M17 M17 M19 M23 M30 M21 M16 M18 M19 M
InterestExpenseOperating-20 M-30 M-20 M-20 M-20 M
MiscOtherSpecialCharges104 M-1000000.0-4 M-5 M-1 M4 M8 M12 M13 M3 M
Net income from total operations389 M811 M495 M570 M584 M722 M1,047 M823 M1,503 M1,522 M
NetIncomeCommonStockholders389 M811 M495 M570 M584 M722 M1,047 M823 M1,503 M1,522 M
NetIncomeContinuousOperations389 M811 M495 M570 M584 M722 M1,047 M823 M1,503 M1,522 M
NetNonOperatingInterestIncomeExpense-5 M-11 M-9 M-8 M-3 M2 M12 M8 M-1000000.016 M
NonRecurringOperationExpense16 M71 M7 M67 M-64 M330 M98 M405 M21 M77 M
Operating income473 M493 M643 M819 M1,089 M748 M1,147 M898 M1,690 M1,789 M
Operating income before depreciation (EBITDA)584 M1,230 M705 M828 M1,120 M839 M1,282 M1,048 M1,864 M1,953 M
OperatingExpense1,056 M1,205 M1,234 M1,347 M1,544 M1,711 M1,995 M1,989 M2,397 M2,513 M
Other income net6 M1000000.04 M6 M-8 M-10 M-14 M2 M-137 M-38 M
Other special charges7 M14 M
OtherGandA733 M858 M851 M905 M991 M1,089 M1,242 M1,228 M1,494 M
OtherImpairmentOfCapitalAssets6 M-700000.0
OtherOperatingExpenses-18 M-76 M-30 M-29 M700000.0-38 M-55 M-86 M-82 M
RentAndLandingFees26 M23 M23 M23 M27 M27 M
Research & development expense323 M347 M383 M442 M553 M622 M753 M761 M903 M945 M
ResearchExpense323 M347 M383 M442 M553 M622 M753 M761 M903 M945 M
RestructringAndMnAIncome10 M
Revenue per share385 M376 M628 M626 M1,127 M1,112 M1,168 M1,173 M1,168 M
SalariesAndWages-15 M-15 M-19 M
Selling Gen & administrative expense733 M858 M851 M905 M991 M1,089 M1,242 M1,228 M1,494 M1,568 M
SellingAndMarketingExpense1,568 M
SellingExpense1,568 M
Special income/charges-16 M-71 M-7 M-67 M64 M-330 M-98 M-405 M-21 M-76 M
Total Income available for interest expense (EBIT)521 M1,161 M640 M757 M1,038 M761 M1,167 M913 M1,700 M1,787 M
Total common shares outstanding643 M647 M644 M637 M630 M623 M627 M625 M623 M608 M
Total net income389 M811 M495 M570 M584 M722 M1,047 M823 M1,503 M1,522 M
Total ordinary shares607 M607 M607 M607 M607 M607 M607 M607 M607 M607 M
Total revenues2,046 M2,323 M2,494 M2,964 M3,435 M3,723 M4,348 M4,386 M5,233 M5,382 M
TotalExpenses1,573 M1,830 M1,851 M2,144 M2,419 M2,650 M3,109 M3,070 M3,646 M3,593 M
TotalRevenue2,046 M2,323 M2,494 M2,964 M3,435 M3,723 M4,348 M4,386 M5,233 M5,382 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

We respect your privacy and will never share your email.
MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University